BOT — Botanix Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$284.36m
- AU$242.68m
- AU$5.76m
Annual cashflow statement for Botanix Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 6.99 | 2.79 | 3.73 | 0.076 | 3.38 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.97 | -11.2 | -12.1 | -8.13 | -78.6 |
| Capital Expenditures | -0.008 | -2.92 | -7.05 | -18 | -1.05 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.008 | -2.92 | -7.05 | -18 | -1.05 |
| Financing Cash Flow Items | 0 | — | -1.44 | -5.76 | -3.31 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.126 | -0.152 | 22 | 95.1 | 65.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.09 | -14.3 | 2.96 | 69.1 | -14.3 |